The Cybin leadership team has a wide range of experience in the cannabis industry, from finance and accounting to marketing and product development. The team is led by CEO Paul Rockwell, who has over 20 years of experience in the pharmaceutical and biotech industries. He is joined by President & Chief Strategy Officer Michael Hartle, who has extensive experience in the cannabis industry, including founding and running Adelia Therapeutics, Inc. (acquired by Cybin Inc). The team also includes Financial Controller David Johnstone, who is a Certified Public Accountant with experience in both the private and public sectors, and Vice President of Finance Craig Loverin, who has over 15 years of experience in the banking and finance industries.
Aaron Bartlone
COO
Alex Kelman
Head of Therapies
Alex Nivorozhkin
Chief Scientific Officer
Allison House-Gecewi...
SVP, Clinical Operations
Amir Inamdar
Chief Medical Officer
Doug Drysdale
CEO
Eric So
President, Executive Chairman ...
Gabe Fahel
Chief Legal Officer
Greg Cavers
CFO
John Kanakis
Co-Founder
Kenneth Avery
SVP, Chemistry & Manufacturing
Lori Challenger
Chief Compliance, Ethics & Adm...
Paul Glavine
Co-Founder & Chief Growth Offi...
Robert Mino
General Counsel & IP Counsel
Ryan Richardson
Director, Information Technolo...
View all